News

Researchers from the Göttingen Cluster of Excellence Mutliscale Bioimaging (MBExC) have uncovered the 3D structure of the membrane proteins myoferlin and dysferlin using high-resolution cryo-electron microscopy. The findings enable new approaches for the development of targeted drugs for the treatment of diseases such as muscle atrophy, hearing disorders and certain

The University of Göttingen has been turned down for the Excellence Strategy of the German national and state governments: funding for the Multiscale Bioimaging (MBExC) Cluster of Excellence will not be extended. This was announced today by the Excellence Commission, the joint committee of the German Research Foundation (DFG) and

MBExC member Prof. Dr. Timo Betz and his team received the audience award in the science category of the startup competition LIFT-OFF 2025 of the University of Göttingen for their project „ArtifiCell“. The group offers solutions for growing and analysing human 3D miniature tissues in order to test and develop

Under the leadership of the University Medical Center Göttingen (UMG), researchers in Göttingen, together with audiologists and artists from the fields of film and music, have translated the sound experience with an optogenetic cochlear implant into images and sound. The music video artistically conveys the restoration of ‘hearing with light’,

Frankfurter Allgemeine Sonntagszeitung reports on hearing research in Göttingen: A new dimension of hearing for those who are deaf or extremely hard of hearing. A large research network in Göttingen around MBExC member Tobias Moser is developing a high-tech hearing aid that uses light and genetic engineering to enable hearing.

Scientists from the ‘Molecular Pharmacology’ working group at the Institute of Pharmacology and Toxicology at the University Medical Center Göttingen (UMG) have been awarded this year’s Oskar Lapp Research Award. Dr. Funsho Fakuade, postdoctoral researcher, and medical students Dominik Hubricht and Vanessa Möller were presented with the award at the

Within the framework of the Research Training Group (RTG) 2824 “Heart & Brain diseases: integrative research across organs”, MBExC member Tobias Brügmann and scientists from the RTG2824 had the exciting opportunity to show students of the Otto-Hahn-Gymnasium (OHG) in Göttingen the fascinating connections between the heart and brain. The session

Founded in January 2025, Ovo Labs is a biotech company that has emerged from the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen (Germany). The company develops novel therapeutics to improve the quality of human eggs. The active compounds are designed to help women remain fertile for longer and

110 scientists clearly affirm their commitment to animal research: “We conduct animal experiments!”   On the occasion of the World Day for Laboratory Animals on 24 April 2025, 110 leading scientists from Germany (including MBExC members) are publicly affirming their commitment to animal research. Under the joint statement “We conduct

With the signing of an equity agreement on April 2, 2025, biotech pioneers Repairon GmbH and life science investor Bioventure Management GmbH, both based in Göttingen, have entered into a strategic partnership with the potential to fundamentally change the treatment of heart failure worldwide. Bioventure is investing in Repairon –